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To understand why some people live to advanced age in good health and others do not, it is
important to study not only disease, but also long-term good health. The Super-Seniors
Study aims to identify factors associated with healthy aging.
Methods
480 healthy oldest-old ‘Super-Seniors’ aged 85 to 105 years and never diagnosed with can-
cer, cardiovascular disease, diabetes, dementia, or major pulmonary disease, were com-
pared to 545 mid-life controls aged 41–54, who represent a group that is unselected for
survival from late-life diseases. Health and lifestyle information, personal and family medical
history, and blood samples were collected from all participants. Super-Seniors also under-
went four geriatric tests.
Results
Super-Seniors showed high cognitive (Mini-Mental State Exam mean = 28.3) and functional
capacity (Instrumental Activities of Daily Living Scale mean = 21.4), as well as high physical
function (Timed Up and Go mean = 12.3 seconds) and low levels of depression (Geriatric
Depression Scale mean = 1.5). Super-Seniors were less likely to be current smokers than
controls, but the frequency of drinking alcohol was the same in both groups. Super-Seniors
were more likely to have 4 or more offspring; controls were more likely to have no children.
Female Super-Seniors had a mean age of last fertility 1.9 years older than controls, and
were 2.3 times more likely to have had a child at 40 years. The parents of Super-Seniors
had mean ages of deaths of 79.3 years for mothers, and 74.5 years for fathers, each
exceeding the life expectancy for their era by a decade.
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Conclusions
Super-Seniors are cognitively and physically high functioning individuals who have evaded
major age-related chronic diseases into old age, representing the approximately top 1% for
healthspan. The familiality of long lifespan of the parents of Super-Seniors supports the
hypothesis that heritable factors contribute to this desirable phenotype.
Introduction
Healthy aging and extreme longevity are phenotypes that many hope to achieve. For many,
however, old age is accompanied by poor health. Longevity refers to the length of time an indi-
vidual lives, their lifespan, whereas healthy aging refers to a person’s ‘health span’. The major-
ity of longevity can be attributed to environmental and lifestyle factors; however, 15–30% of
adult lifespan is heritable [1]. While the heritability of longevity is minimal before age 60, it
increases at more advanced ages [2]. Some longevity genes have been identified in model
organisms; however, few findings have been replicable in humans with the exceptions of
APOE and FOXO3, reviewed in [3].
According to the US Centre for Disease Control, the leading causes of death over the age of
65, in descending order, are: diseases of the heart, malignant neoplasms, chronic lower respira-
tory diseases, cerebrovascular disease, Alzheimer disease (AD), and diabetes mellitus [4]. We
describe here the ascertainment and characterization of 480 oldest old who have never been
diagnosed with any of these diseases.
Several research studies have collected long-lived individuals [5–10], most with the goal of
studying longevity or exceptional longevity. Recent insights have also been gained from large
cross-sectional population studies [11, 12]. The Super-Seniors Study examines individuals
over 85 with a well-characterized health phenotype free of five specific major age-related dis-
eases, in order to study healthy aging. This focus is shared by the Wellderly study [13], which
researches healthy elderly aged 80 and over.
We have collected a group of oldest-old “Super-Seniors”, aged 85 years and older who have
never been diagnosed with cancer, cardiovascular disease (CVD), diabetes, dementia or major
pulmonary disease; as well as a group of mid-life controls recruited randomly with respect to
health. The Super-Seniors represent a group of individuals who have not only survived to at
least 85, but have done so free of the major chronic diseases that lead to decreased quality of
life and early death. The Super-Senior phenotype is also economically relevant—the diseases
they have evaded are among the most common and therefore expensive to provide care for
within a healthcare system. Because most individuals in developed countries live to at least age
50, the mid-life group represents a set of individuals who are as yet unselected for the age-
related diseases that the Super-Seniors have avoided.
To some, 85 years may now seem too young to be considered long-lived [14]. While indi-
viduals born more recently have tended to live longer, for those born in the years that the
Super-Seniors were, reaching 85 years was quite a feat (S1 Fig).
Future work will compare the Super-Seniors to population-based mid-life controls as a
strategy to identify genetic factors that may contribute to their long-term good health. Here we
characterize the health, family history and lifestyle of the Super-Seniors.
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Methods
Recruitment
This study was approved by the University of British Columbia (BC)-BC Cancer Agency
Research Ethics Board and the Research Ethics Board of Simon Fraser University. All partici-
pants gave written informed consent.
Eligibility criteria for being a Super-Senior included: being 85 years or older and self-
reporting as never having had cancer (except non-melanoma skin cancer), CVD, diabetes,
dementia, or major pulmonary disease (except asthma). Controls were aged 41–54 years and
not selected for health.
Using lists from the BC Ministry of Health Medical Services Plan (MSP), which includes
98% of BC residents, we contacted individuals living in Metro Vancouver, BC, Canada 85 or
older, or 40–50 years old. Additional invitations were sent to potential controls accompanied
by an offer of a $50 honorarium. Super-Seniors were also identified by BC Stats, which had
confidential access to the Insurance Corporation of BC drivers license database and could
allow contact of currently licensed drivers, or were those who volunteered following press cov-
erage. In an attempt to collect additional Super-Seniors of Asian ancestry, advertisements were
placed in Chinese-language newspapers. Finally, to collect a greater number of European con-
trols, later mail-outs included only midlife individuals with non-Asian surnames.
After initial contact by mail, potential Super-Seniors were screened by phone to determine
eligibility. After receiving written informed consent, a home or telephone interview was
arranged for Super-Seniors and controls, respectively. Ascertainment and sample collection
took place between 2004 and 2007, resulting in the shifting age range from the intended 40–50
to 41–54.
Data collection
Super-Seniors were visited at home by an interviewer and asked for personal and family medi-
cal history, to show all prescription and non-prescription medications, and to perform geriat-
ric tests. Test scores did not affect eligibility.
Controls were asked the same personal/family medical history questions, but were not
selected for health or disease status.
Ethnicity of the four grandparents was collected, and a composite ethnicity was determined
for each participant. A participant’s ethnicity was categorized as unknown if they did not
know the ethnicity of all four grandparents. If participants were unsure about the age of death
of their parents, an approximation was made; for example, ‘mid-sixties’ was approximated as
65 years.
30mL of non-fasting blood was drawn from each participant. Super-Seniors were visited by
a phlebotomist; controls visited a commercial clinical laboratory. DNA was extracted using the
PureGene DNA isolation kit (Gentra Systems, MN).
Phenotypic review
Health data of the Super-Seniors were reviewed and potential cases were excluded based on
presence of disease but not based on intermediate phenotypes such as high blood pressure.
Medications were reviewed and potential Super-Seniors excluded if they were taking a drug
used exclusively to treat cancer, CVD, dementia, pulmonary disease or diabetes. Participants
with borderline health status (generally those with an asymptomatic arrhythmia or chronic
bronchitis) were excluded from subsequent analyses.
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Statistical analysis
Statistical tests were run in JMP Version 11 [15].
Results
Recruitment
Recruitment is summarized in Fig 1 and S2 Fig. An initial mailing was sent to BC MSP sub-
scribers: 8415 individuals aged 85 or more, and 3920 aged 40–50. Of potential Super-Seniors,
4261 (50.6%) had incorrect contact information, were unable to be contacted, or did not speak
English; 628 (7.5%) were deceased; 1059 (12.6%) refused without determining eligibility; 2161
(25.7%) were not eligible; and 306 (3.6%) participated. Of the potential controls, 2884 (73.6%)
had incorrect contact information, were unable to be contacted, or did not speak English; 491
(12.5%) refused, and 545 (13.9%) participated. 12.4% of potential Super-Seniors who were
interested were eligible. The consent rate for controls was 52.6% (S2 Fig).
In addition to those identified through BC MSP, 160 Super-Seniors volunteered and 94
were identified by BC Stats. After review of interview data and medications, 63 individuals
were excluded and 17 were borderline, resulting in 480 Super-Seniors and 545 controls.
Descriptive statistics
There were 325 female and 155 male (32.3%) Super-Seniors and 336 female and 209 male
(38.3%) controls (Table 1 and S3 Fig). Super-Seniors were aged 85–105 (mean 88.5 years);
Fig 1. Recruitment of Super-Seniors and controls.
https://doi.org/10.1371/journal.pone.0197578.g001
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controls were aged 41–54 (mean 46.7 years). 92.5% of Super-Seniors and 76.3% of controls
were of European ancestry (Fig 1 and S1 Table). Super-Seniors had a mean BMI of 25.7 (SD
4.7), while controls had a mean BMI of 24.5 (SD 3.9).
Functional tests
Super-Seniors scored high on the Mini-Mental State Exam (MMSE) [16], mean = 28.3 (SD
1.7) and Instrumental Activities of Daily Living Scale (IADL) [17], mean = 21.4 (SD 3.5), and
low on the Timed Up and Go test (TUG) [18], mean = 12.3 seconds (SD 4.3) and Geriatric
Depression Scale (GDS) [19], mean = 1.5 (SD 1.8) (Fig 2). Inability to complete the MMSE as a
result of vision deficits resulted in 35 scores being excluded. The TUG was not administered if
Table 1. Characteristics of the study participants.
Super-Seniors Controls
Male Female Total Male Female Total
Descriptive statistics N 155 325 480 209 336 545
Age—mean (SD) 88.7 (2.9) 88.5 (2.9) 88.5 (2.9) 46.8 (3.2) 46.6 (3.4) 46.7 (3.3)
Range (years) 85–100 85–105 85–105 41–53 41–54 41–54
Birth year—mean 1916 1916 1916 1958 1958 1958
BMI—mean (SD) 25.0 (3.4) 24.3 (4.1) 24.5 (3.9) 26.7 (4.0) 25.0 (5.0) 25.7 (4.7)
Range (kg/m2) 19.0–42.5 15.1–42.1 15.1–42.5 18.4–46.8 16.8–48.4 16.8–48.4
Smoking Smoker—current (%) 4 (2.6) 3 (0.9) 7 (1.5) 25 (12.0) 33 (9.8) 58 (10.6)
Smoker—never (%) 52 (33.5) 189 (58.2) 241 (50.2) 107 (51.2) 161 (47.9) 268 (49.2)
Smoker—quit (%) 99 (63.9) 133 (40.9) 232 (48.3) 77 (36.8) 142(42.3) 219 (40.2)
Years smoked (among quitters)—mean (SD) 31.9 (17.4) 27.8 (17.8) 29.4 (17.8) 14.5 (10.2) 13.5 (8.6) 13.8 (9.2)
Pack years smoked (among quitters)—mean (SD) 24.7 (28.2) 15.4 (20.8) 19.3 (24.6) 10.3 (10.9) 9.1 (9.4) 9.6 (9.9)
Activity Activity—none (%) 25 (16) 71 (22) 96 (20) 51 (24) 81 (24) 132 (24)
Activity—walking (%) 54 (35) 95 (29) 149 (31) 24 (11) 66 (20) 90 (17)
Activity—exercise (%) 75 (49) 158 (49) 233 (49) 134 (64) 186 (56) 320 (59)
Alcohol Alcohol—beer (%) 28 (6) 24 (5) 52 (11) 130 (24) 75 (14) 205 (38)
Alcohol—spirits (%) 54 (11) 80 (17) 134 (28) 60 (11) 76 (14) 136 (25)
Alcohol—wine (%) 76 (16) 180 (38) 256 (53) 125 (23) 225 (41) 350 (64)
Alcohol—none (%) 32 (7) 91 (19) 123 (26) 29 (5) 59 (11) 88(16)
Fertility Number of offspring 2.6 (1.6) 2.5 (1.7) 2.6 (1.7) 1.5 (1.2) 1.7 (1.2) 1.6 (1.2)
Range 0–12 0–8 0–12 0–5 0–5 0–5
Had offspring 131 284 415 139 248 387
Age of last fertility—mean (SD) 35.8 (6.3) 33.7 (5.8) - 34.1 (5.6) 31.8 (5.1) -
Range (years) 23–54 19–47 - 20–47 17–45 -
Had offspring 40+ years 34 47 - 25 20 -
Age of 40+ parents—mean (SD) 44.1 (3.4) 42.6 (2.2) - 42.4 (1.9) 41.3 (1.6) -
Had offspring 35+ years 68 128 - 63 75 -
Age of 35+ parents—mean (SD) 40.7 (4.3) 38.8 (3.4) - 39.2 (3.0) 37.9 (2.4) -
Parents Maternal age of death 79.6 (15.6) 79.1 (15.6) 79.3 (15.6) - - -
Paternal age of death 75.0 (15.9) 74.2 (16.1) 74.5 (16.0) - - -
Geriatric tests TUG—mean (SD) 12.2 (4.0) 12.3 (4.5) 12.3 (4.3) - - -
MMSE—mean (SD) 28.1 (1.7) 28.4 (1.7) 28.3 (1.7) - - -
GDS—mean (SD) 1.5 (1.8) 1.6 (1.8) 1.5 (1.8) - - -
IADL—mean (SD) 21.7 (3.0) 21.2 (3.7) 21.4 (3.5) - - -
Categories are not mutually exclusive
https://doi.org/10.1371/journal.pone.0197578.t001
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the participant was not able to ambulate independently. Seven MMSE, 15 TUG, and 6 GSD
scores were missing. No differences were detected between the scores for men and women for
any test.
Lifestyle
Smoking status was divided into current, never, and quit (Table 1). Controls were 8.0 fold
more likely to be current smokers than cases (95%CI = 3.36–15.8, p<0.0001)(S2 Table). There
was a difference in proportion between male and female never smokers and quitters in Super-
Seniors (X2 = 24.2, p<0.0001): female Super-Seniors were more likely to be never smokers
(58.7%) than men (34.4%), and men were more likely to be quitters (65.6%) than women
(41.3%). No difference in smoking status was detected between sexes in controls.
Among quitters, Super-Seniors smoked a mean of 29.4 years (SD = 17.8) and 19.3 pack
years (SD = 24.6) (pack year = packs smoked/dayyears smoked); whereas controls who quit
smoked a mean of 13.8 years (SD = 9.2) and 9.6 pack years (SD = 9.9). Although there was no
difference in the mean number of years that male and female Super-Seniors smoked, male
Super-Seniors smoked more heavily, for a mean of 9.32 pack years more than females
(SE = 3.4, 95%CI = 2.6–16.0, p = 0.007). Super-Senior quitters started smoking at a mean age
of 20.5 years (SD = 8.1) and quit at a mean age of 50.0 years (SD = 18.2); control quitters
started smoking at a mean age of 16.6 years (SD = 3.3) and quit at a mean age of 30.5 years
(SD = 8.8).
49% of Super-Seniors and 59% of controls reported exercising (X2 = 10.44, p<0.0012), with
controls more likely to engage in exercise other than walking. No significant difference was
observed in the proportion of Super-Seniors and controls who drank alcohol.
Fig 2. Distribution of functional test scores of the Super-Seniors.
https://doi.org/10.1371/journal.pone.0197578.g002
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Number of offspring and age of fertility. There was a difference in the proportion of
number of offspring between Super-Seniors and controls (X2 = 107.0, p<0.0001)(S3 Table).
Super-Seniors had a mean number of offspring (2.6, SD = 1.7) that was higher than controls
(mean = 1.6, SD = 1.2);
284 Super-Senior and 248 control females gave birth. Super-Senior women had a mean age
of last fertility 1.9-years older than control women (SE = 0.5, 95%CI = -2.8– -1.9, p<0.0001).
There was no evidence of a difference in mean age of first fertility. Super-Senior men also had
their last child a mean of 1.7 years older than control men (SE = 07, 95%CI = -0.2– -3.1,
p = 0.011).
47 (16.5%) Super-Seniors and 20 (8.1%) controls who reproduced gave birth at40 years,
at a mean age of 42.6 (SD = 2.2) and 41.3 (SD = 1.6) years, respectively. 128 (45.1%) Super-
Seniors and 75 (30.2%) controls gave birth35, at a mean age of 38.8 (SD = 3.4) and 37.9
(SD = 2.4). Among women who gave birth, Super-Seniors were 2.3 times more likely to have
had a child at40 years (95%CI = 1.3–3.9, p = 0.004), and 1.9 times more likely to have had a
child at35 years (95%CI = 1.3–2.7).
The parents of Super-Seniors lived longer than their contemporaries. The Super-
Seniors reported their parents’ age at death to be between 21–110 years for their mothers
(mean = 79.3, SD = 15.6), and 26–102 years for their fathers (mean = 74.5, SD = 16.0). The
control parents’ ages of death ranged from 26 years to still alive for mothers, and 29 to still
alive for fathers.
The parents of the Super-Seniors were born between ~1880–1905. The earliest survival sta-
tistics for North America are Americans born in 1900 [4]. We compared age at death of the
parents of Super-Seniors (who we know lived to reproductive age) to individuals born in 1900
who survived to age 21. 50% of 21 year olds born in 1900 lived to 67 years (66 for men, 68 for
women). The mothers and fathers of the Super-Seniors therefore lived 11.3 and 8.5 years (aver-
age of 9.9 years) longer than the 1900 birth cohort.
Discussion
We have established a collection of healthy oldest-old and a mid-life control group recruited
from population-based lists. Here, we describe the characteristics and cognitive and physical
function of the Super-Seniors. We also document major lifestyle factors such as smoking and
alcohol consumption to allow adjustment for these factors in future genetic analyses.
Hidden differences in ethnicities in case-control studies can lead to false positive genetic
findings. Early in recruitment, we noted a difference in ethnicity between the Super-Seniors
and controls. Over time, Metro Vancouver has seen increasing immigration by non-European
groups. We attempted to equalize the composition of the two groups by identifying Asian-
ancestry Super-Seniors, with little success, so instead over-collected controls of European
ancestry.
We define the Super-Senior phenotype as oldest-old (85 years) who have never been diag-
nosed with any of five major diseases that are the leading causes of death over the age of 65 [4].
12.4% of seniors over age 85 who were contactable and interested were eligible. Given that
28.5% of Canadians age 85 or older have dementia [20], the eligibility rate of living individuals
is therefore closer to 8.9%. Furthermore, only 9.0% of individuals born in 1916 lived to be 85
[21]. The proportion of the 1916 birth cohort who went on to become Super-Seniors is there-
fore approximately 0.80%, making Super-Senior status the ‘top 1%’ elite health and survival
phenotype.
Super-Seniors had a mean TUG of 12.3 seconds, indicating that the majority are able to
ambulate independently [18]. The Newcastle 85+ Study observed a baseline TUG of
Phenotype of healthy 85+ Super-Seniors
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18.6 ± 14.7 (n = 735) and a 5-year follow-up TUG of 20.7 ± 12.0 (n = 271) [22]. A study of
community-dwelling Taiwanese individuals 65+ years of age found that physical fitness indica-
tors, including the TUG, are associated with successful aging [23].
The median MMSE score of the Super-Seniors was 29, with a single participant scoring
<19. In the Leiden Longevity Study, [10] (men 89+, women 91+) the median MMSE score
was 25 and 14% scored <19. In the Taiwanese study only 73.5% had an MMSE24 [23]. By
selecting for a disease-free state that excluded dementia, the Super-Seniors are a cognitively
high functioning group, even when compared to other long-lived groups.
A GDS score 5 has been found to be a sensitive and specific cutoff for depression [24].
The Super-Seniors had a mean GDS score of 1.5. The IADL assesses performance of daily tasks
[17]. Although the mean IADL score of Super-Seniors was high, there were a few low scores,
with the three lowest belonging to individuals who used wheelchairs. Because a minority of
participants lived with family or in an assisted living community, lower IADL scores in some
instances reflected their responsibilities rather than their abilities.
Several differences between the Super-Seniors and controls are expected and reflect popula-
tion trends over time, including smoking habits and family size. Super-Senior women were
less likely to be smokers than Super-Senior men, but there was no difference between male
and female smoking rates in the controls. This is consistent with Canadian smoking trends
[25]. Controls were more likely to be current smokers; one reason for this is that some smokers
in the Super-Senior age range would likely have developed smoking-related diseases that
would make them ineligible. There was no evidence of a difference in the proportion of Super-
Seniors and controls who drank alcohol.
There were higher proportions of controls having no offspring and Super-Seniors having
4+ offspring. This likely reflects changes in family size over time; however, some controls in
their early 40s could go on to have additional offspring.
Super-Senior women had an older mean age of last fertility and were 2.3 times more likely
to give birth at40 years, compared to controls. Associations have been found between late
childbirth (40+) and increased survival in women [26–28]. Female centenarians were four
times more likely to have had children in their forties than a group from the same birth year
who died at age 73 [29]. Late fertility, and more specifically the ability to bear a child after age
40, may be a sign of slower biological aging [29]. On average, Super-Senior fathers had their
last child at an older age than control fathers, suggesting that in some cases the advanced
maternal age of the Super-Senior women may have been because they had to wait until after
the war to start their families.
Super-Senior parents lived substantially longer than their contemporaries, suggesting a
familial tendency towards long life. The true difference in lifespan is probably greater, as many
of the parents of the Super-Seniors were likely born before 1900, when life expectancy was
even lower.
The mid-life control group is intended for use only for genetic comparisons with the Super-
Seniors, not for epigenetics or formal comparison of lifestyle or other non-genetic factors. The
latter quantities cannot be compared between these groups because they have lived in different
eras and would be expected to show potentially confounding cohort effects.
The ideal control group for the Super-Seniors would be individuals from the same birth
cohort who did not successfully achieve the Super-Senior phenotype. Clearly it is not feasible
to obtain DNA from such a control group. Instead, we use the strategy of comparing the elite
Super-Seniors to a group that has not been selected for survival in later life. From the survival
curves in S1B Fig, in 1958 (the mean birth year of the controls), the curve is nearly flat until
approximately age 50 because relatively few people born in 1958 died before that age; they
were therefore largely unselected for survival up to that point.
Phenotype of healthy 85+ Super-Seniors
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If we were to compare Super-Seniors to age-matched individuals, we would be comparing
healthy oldest old to unhealthy oldest old. Such individuals would have in common the fact
that they all survived to at least age 85, and the phenotypic (and presumably genotypic) differ-
ences between them would be more subtle, and harder to detect, than those that could differ
between the highly selected Super-Seniors vs. the largely unselected mid-life individuals.
Importantly, an age-matched control group does not allow us to study genetic factors that
affect survival to the oldest-old age category, or those genetic factors that might influence both
survival and health late in life.
A limitation of our study design is that the midlife group is expected to contain a small
minority of people (approximately 1%) who would have been destined to become Super-
Seniors, had they been born circa 1916 (we note that being born in 1916 and surviving to 85,
or being born in 1958 and surviving to 85, are not the same survival phenotype because the
threats to survival and health differ between the two eras). The presence of such rare individu-
als amongst the midlife controls slightly reduces the statistical power of the study. Another
limitation is that small sample size limits the statistical power of the current sample set. To
overcome this limitation a Phase 2 recruitment is in progress; we also intend to combine the
data from the Super-Seniors Study with aging consortia for meta-analyses once we have com-
pleted initial genetic analyses. We plan a future recruitment of age-matched less healthy elderly
to use as another comparison population.
We have established and characterized an initial cohort in which to study the genetics of
healthy aging [30–33], with Super-Seniors representing an elite group in terms of healthspan.
The study that is most comparable to the Super-Seniors is the Wellderly Study of healthy
elderly aged 80 and older [13]. While healthy aging is defined similarly between these two
studies, the Super-Seniors are on average 4.3 years older (average 88.5 years vs. 84.2 years) and
have a higher proportion of women (67.7% vs. 60.7%). Geriatric test scores demonstrate that
Super-Seniors are a cognitively and physically high functioning group in addition to being
healthy oldest old. The long lifespan of the parents of Super-seniors supports the hypothesis
that heritable factors contribute to this desirable phenotype.
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